Cargando…

Deciphering the mechanisms of Yinlan Tiaozhi capsule in treating hyperlipidemia by combining network pharmacology, molecular docking and experimental verification

Yinlan Tiaozhi capsule (YLTZC) has been widely used to treat hyperlipidemia (HLP). However, its material basis and underlying pharmacological effects remain unclean. The current study aimed to explore the mechanisms involved in the treatment of YLTZC on HLP based on network pharmacology, molecular d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Guanlin, Hu, Zixuan, Jia, Canchao, Yang, Minjuan, Li, Dongmei, Xu, Aili, Jiang, Jieyi, Chen, Zhao, Li, Yangxue, Li, Sumei, Chen, Weitao, Zhang, Jingnian, Bi, Xiaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115829/ https://www.ncbi.nlm.nih.gov/pubmed/37076581 http://dx.doi.org/10.1038/s41598-023-33673-3

Ejemplares similares

Metabolomics analysis delineates the therapeutic effects of Yinlan Tiaozhi capsule on triton WR-1339 -induced hyperlipidemia in mice
por: Xiao, Guanlin, et al.
Publicado: (2023)

Network pharmacology analysis and experimental validation to explore the mechanism of Bushao Tiaozhi capsule (BSTZC) on hyperlipidemia
por: Xiao, Guanlin, et al.
Publicado: (2022)

Long-Term Effect of Zhenzhu Tiaozhi Capsule (FTZ) on Hyperlipidemia: 2-Year Results from a Retrospective Study Using Electronic Medical Records
por: Huang, Xiaoqiang, et al.
Publicado: (2021)

Network Pharmacology and Molecular Docking-Based Prediction of the Mechanism of Qianghuo Shengshi Decoction against Rheumatoid Arthritis
por: Zeng, Zhihao, et al.
Publicado: (2021)

Fufang-Zhenzhu-Tiaozhi Capsule reduces restenosis via the downregulation of NF-kappaB and inflammatory factors in rabbits
por: Zhang, Rendan, et al.
Publicado: (2018)

Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis
por: Lan, Tian, et al.
Publicado: (2022)

Traditional Chinese Medicine Fufang-Zhenzhu-Tiaozhi capsule prevents renal injury in diabetic minipigs with coronary heart disease
por: Song, Lixia, et al.
Publicado: (2022)

Effects of Tiaozhi Granule on Regulation of Autophagy Levels in HUVECs
por: Wu, Ying-Ying, et al.
Publicado: (2018)

Analysis of the Constituents in Rat Serum after Oral Administration of Fufang Zhenzhu Tiaozhi Capsule by UPLC–Q–TOF–MS/MS
por: Zhong, Xunlong, et al.
Publicado: (2011)

Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet
por: Chen, Zhe, et al.
Publicado: (2022)

Study on Metabolic Trajectory of Liver Aging and the Effect of Fufang Zhenzhu Tiaozhi on Aging Mice
por: Luo, Duosheng, et al.
Publicado: (2019)

Untargeted Metabolomics Reveals the Protective Effect of Fufang Zhenshu Tiaozhi (FTZ) on Aging-Induced Osteoporosis in Mice
por: Luo, Duosheng, et al.
Publicado: (2019)

The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Wang, Lexun, et al.
Publicado: (2021)

The therapeutic effect of Fufang Zhenshu Tiaozhi (FTZ) on osteoclastogenesis and ovariectomized-induced bone loss: evidence from network pharmacology, molecular docking and experimental validation
por: Chen, Xiaojun, et al.
Publicado: (2022)

The Target MicroRNAs and Potential Underlying Mechanisms of Yiqi-Bushen-Tiaozhi Recipe against‐Non-Alcoholic Steatohepatitis
por: Hong, Wei, et al.
Publicado: (2020)

Naoxintong Capsule Alternates Gut Microbiota and Prevents Hyperlipidemia in High-Fat-Diet Fed Rats
por: Lu, Yihang, et al.
Publicado: (2022)

Shuangyu Tiaozhi Granule Attenuates Hypercholesterolemia through the Reduction of Cholesterol Synthesis in Rat Fed a High Cholesterol Diet
por: Shi, Jingjing, et al.
Publicado: (2019)

Deciphering the underlying mechanism of Xianlinggubao capsule against osteoporosis by network pharmacology
por: Bao, Hangsheng, et al.
Publicado: (2020)

Metabolomic and Microbial Remodeling by Shanmei Capsule Improves Hyperlipidemia in High Fat Food-Induced Mice
por: Du, Lijing, et al.
Publicado: (2022)

Effects of Extracts from Tiaozhi Granule and Its Components on Expression of Scavenger Receptor Class B Type I
por: Yu, Xiao, et al.
Publicado: (2016)

Efficacy and Mechanism of the Jiangtang Tiaozhi Recipe in the Management of Type 2 Diabetes and Dyslipidaemia: A Clinical Trial Protocol
por: Wu, Haoran, et al.
Publicado: (2022)

Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota
por: Yan, Junbin, et al.
Publicado: (2022)

Effect of Xuefu Zhuyu Capsule on Myocardial Infarction: Network Pharmacology and Experimental Verification
por: Duan, Jinlong, et al.
Publicado: (2023)

Herbal medicine formula Huazhuo Tiaozhi granule ameliorates dyslipidaemia via regulating histone lactylation and miR-155-5p biogenesis
por: Yin, Xiangjun, et al.
Publicado: (2023)

Exploring the Regulation of Jiangtang Tiaozhi Formula on the Biological Network of Obese T2DM Complicated With Dyslipidemia Based on Clinical Transcriptomics
por: Bao, Tingting, et al.
Publicado: (2022)

Deciphering the Pharmacological Mechanisms of Guizhi-Fuling Capsule on Primary Dysmenorrhea Through Network Pharmacology
por: Zhang, Siqin, et al.
Publicado: (2021)

Comprehensive multiomics analysis of the effect of ginsenoside Rb1 on hyperlipidemia
por: Lianqun, Jia, et al.
Publicado: (2021)

Network pharmacology analysis and clinical verification of Jishe Qushi capsules in rheumatoid arthritis treatment
por: Li, Yujie, et al.
Publicado: (2023)

Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo
por: Yin, Guoliang, et al.
Publicado: (2022)

Deciphering the role of the capsule of Klebsiella pneumoniae during pathogenesis: A cautionary tale
por: Rendueles, Olaya
Publicado: (2020)

Monogenic hyperlipidemias
por: Krasi, Geraldo, et al.
Publicado: (2019)

Hyperlipidemias and Obesity
por: Thiriet, Marc
Publicado: (2019)

The proteomic data of liver in mice with hyperlipidemia
por: Song, Pingping, et al.
Publicado: (2021)

A network pharmacology-based strategy deciphers the underlying molecular mechanisms of Qixuehe Capsule in the treatment of menstrual disorders
por: Zhang, Yanqiong, et al.
Publicado: (2017)

Network Pharmacology-Based Approach to Investigate the Mechanisms of Mahai Capsules in the Treatment of Cardiovascular Diseases
por: Shi, Minjuan, et al.
Publicado: (2020)

The Potential Mechanism of Wuwei Qingzhuo San against Hyperlipidemia Based on TCM Network Pharmacology and Validation Experiments in Hyperlipidemia Hamster
por: Li, Jianliang, et al.
Publicado: (2020)

Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Dai, Liang, et al.
Publicado: (2016)

Hyperlipidemia Is a Risk Factor of Adhesive Capsulitis: Real-World Evidence Using the Taiwanese National Health Insurance Research Database
por: Wang, Jr-Yi, et al.
Publicado: (2021)

Integrating network pharmacology and experimental verification strategies to reveal the active ingredients and molecular mechanism of Tenghuang Jiangu Capsule against osteoporosis
por: Li, Miao, et al.
Publicado: (2023)

Hyperlipidemia and lipedematous scalp
por: Bukhari, Iqbal, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_9uinviut2iolfjbb6j4f4s89bl